» Articles » PMID: 33794890

Apigenin Role As Cell-signaling Pathways Modulator: Implications in Cancer Prevention and Treatment

Overview
Journal Cancer Cell Int
Publisher Biomed Central
Date 2021 Apr 2
PMID 33794890
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Cancer is a complex disease orchestrated by various extrinsic and intrinsic pathways. In recent years, there has been a keen interest towards the development of natural extracts-based cancer therapeutics with minimum adverse effects. In pursuit of effective strategy, a wide variety of natural products-derived compounds have been addressed for their anticancer effects. Apigenin is a naturally-occurring flavonoid present abundantly in various fruits and vegetables. Decades of research have delineated the pharmacological and biological properties of apigenin. Specifically, the apigenin-mediated anticancer activities have been documented in various types of cancer, but the generalized scientific evidence encompassing various molecular interactions and processes, such as regulation of the apoptotic machinery, aberrant cell signaling and oncogenic protein network have not been comprehensively covered. In this sense, in this review we have attempted to focus on the apigenin-mediated regulation of oncogenic pathways in various cancers. We have also addressed the cutting-edge research which has unveiled the remarkable abilities of apigenin to interact with microRNAs to modulate key cellular processes, with special emphasis on the nano-formulations of apigenin that can help their targeted delivery and can be a therapeutic solution for the treatment of various cancers.

Citing Articles

Modulating NLRP3 Inflammasomes in Idiopathic Pulmonary Fibrosis: A Comprehensive Review on Flavonoid-Based Interventions.

Vithalkar M, Pradhan S, Sandra K, Bharath H, Nayak Y Cell Biochem Biophys. 2025; .

PMID: 39966334 DOI: 10.1007/s12013-025-01696-4.


Bee Pollen Phytochemicals and Nutrients as Unequaled Pool of Epigenetic Regulators: Implications for Age-Related Diseases.

Kacemi R, Campos M Foods. 2025; 14(3).

PMID: 39941940 PMC: 11816923. DOI: 10.3390/foods14030347.


Promising antiviral inhibitors against lumpy skin disease: A vetinformatics approach.

Krishna S, Sarkar A, Banerjee S, Panja A Open Vet J. 2024; 14(11):2806-2816.

PMID: 39737031 PMC: 11682754. DOI: 10.5455/OVJ.2024.v14.i11.9.


Phytochemicals in Cancer Chemoprevention: Preclinical and Clinical Studies.

Lekhak N, Bhattarai H Cancer Control. 2024; 31:10732748241302902.

PMID: 39629692 PMC: 11615997. DOI: 10.1177/10732748241302902.


Apigenin as a Promising Agent for Enhancing Female Reproductive Function and Treating Associated Disorders.

Sirotkin A, Harrath A Biomedicines. 2024; 12(10).

PMID: 39457717 PMC: 11504338. DOI: 10.3390/biomedicines12102405.


References
1.
Shukla S, Gupta S . Apigenin-induced cell cycle arrest is mediated by modulation of MAPK, PI3K-Akt, and loss of cyclin D1 associated retinoblastoma dephosphorylation in human prostate cancer cells. Cell Cycle. 2007; 6(9):1102-14. DOI: 10.4161/cc.6.9.4146. View

2.
Carneiro B, El-Deiry W . Targeting apoptosis in cancer therapy. Nat Rev Clin Oncol. 2020; 17(7):395-417. PMC: 8211386. DOI: 10.1038/s41571-020-0341-y. View

3.
Mirzoeva S, Franzen C, Pelling J . Apigenin inhibits TGF-β-induced VEGF expression in human prostate carcinoma cells via a Smad2/3- and Src-dependent mechanism. Mol Carcinog. 2013; 53(8):598-609. DOI: 10.1002/mc.22005. View

4.
Braicu C, Zanoaga O, Zimta A, Tigu A, Kilpatrick K, Bishayee A . Natural compounds modulate the crosstalk between apoptosis- and autophagy-regulated signaling pathways: Controlling the uncontrolled expansion of tumor cells. Semin Cancer Biol. 2020; 80:218-236. DOI: 10.1016/j.semcancer.2020.05.015. View

5.
Samadian N, Hashemi M . Effects of Apigenin and Apigenin- Loaded Nanogel on Induction of Apoptosis in Human Chronic Myeloid Leukemia Cells. Galen Med J. 2021; 7:e1008. PMC: 8344127. DOI: 10.22086/gmj.v0i0.1008. View